296 related articles for article (PubMed ID: 26912753)
21. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan.
Hasan B; Perveen K; Olsen B; Zahra R
J Med Microbiol; 2014 Jan; 63(Pt 1):50-55. PubMed ID: 24085817
[TBL] [Abstract][Full Text] [Related]
22. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre.
Kohlenberg A; Brümmer S; Higgins PG; Sohr D; Piening BC; de Grahl C; Halle E; Rüden H; Seifert H
J Med Microbiol; 2009 Nov; 58(Pt 11):1499-1507. PubMed ID: 19589905
[TBL] [Abstract][Full Text] [Related]
23. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Zhang X; Gu B; Mei Y; Wen Y; Xia W
J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
[TBL] [Abstract][Full Text] [Related]
24. Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit.
Karampatakis T; Tsergouli K; Politi L; Diamantopoulou G; Iosifidis E; Antachopoulos C; Karyoti A; Mouloudi E; Tsakris A; Roilides E
Microb Drug Resist; 2019 Jun; 25(5):712-716. PubMed ID: 30589601
[TBL] [Abstract][Full Text] [Related]
25. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
Kunz AN; Brook I
Chemotherapy; 2010; 56(6):492-500. PubMed ID: 21099222
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia.
Apisarnthanarak A; Kiratisin P; Apisarnthanarak P; Mundy LM
Infect Control Hosp Epidemiol; 2011 Apr; 32(4):410-1. PubMed ID: 21460501
[No Abstract] [Full Text] [Related]
27. [Approach to directed therapy after knowledge of the isolate: carbapenemase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii].
Martínez JA
Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():31-4. PubMed ID: 27608310
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics.
Matsumoto S; Singley CM; Hoover J; Nakamura R; Echols R; Rittenhouse S; Tsuji M; Yamano Y
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630178
[TBL] [Abstract][Full Text] [Related]
29. Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
Jiang W; Liu H; Zhong M; Yang YC; Xiao DW; Huang WF
Microb Drug Resist; 2013 Apr; 19(2):117-23. PubMed ID: 22845773
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
[TBL] [Abstract][Full Text] [Related]
31. Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes.
Peleg AY; Bell JM; Hofmeyr A; Wiese P
J Antimicrob Chemother; 2006 Apr; 57(4):794-5. PubMed ID: 16476724
[No Abstract] [Full Text] [Related]
32. [Molecular epidemiology of carbapenem-resistant isolates of Acinetobacter baumannii in Argentina].
H Rodríguez C; Nastro M; A Flores S; Rodriguez M; Spinozzi M; Bruni G; L López A; David V; S Aiassa M; A Marqués I; R Navarro O; Paniccia L; Famiglietti A;
Rev Argent Microbiol; 2019; 51(3):247-250. PubMed ID: 30551810
[TBL] [Abstract][Full Text] [Related]
33.
Guo Y; Han R; Jiang B; Ding L; Yang F; Zheng B; Yang Y; Wu S; Yin D; Zhu D; Hu F;
Microbiol Spectr; 2022 Aug; 10(4):e0185422. PubMed ID: 35862963
[TBL] [Abstract][Full Text] [Related]
34. Swab cultures across three different body sites among carriers of carbapenem-resistant P. aeruginosa and Acinetobacter species: a poor surveillance strategy.
Dalben MF; Oliveira MS; Garcia CP; Lobo RD; Costa SF; Toscano CM; Levin AS
J Hosp Infect; 2010 Apr; 74(4):395-6. PubMed ID: 19717211
[No Abstract] [Full Text] [Related]
35. Controlling multidrug-resistant Gram-negative bacilli in your hospital: a transformational journey.
Munoz-Price LS
J Hosp Infect; 2015 Apr; 89(4):254-8. PubMed ID: 25766464
[TBL] [Abstract][Full Text] [Related]
36. Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of
Lasarte-Monterrubio C; Guijarro-Sánchez P; Bellés A; Vázquez-Ucha JC; Arca-Suárez J; Fernández-Lozano C; Bou G; Beceiro A;
Microbiol Spectr; 2022 Feb; 10(1):e0273421. PubMed ID: 35138195
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and Mechanisms of Carbapenem Resistance in
Nasiri MJ; Zamani S; Fardsanei F; Arshadi M; Bigverdi R; Hajikhani B; Goudarzi H; Tabarsi P; Dabiri H; Feizabadi MM
Microb Drug Resist; 2020 Mar; 26(3):270-283. PubMed ID: 30822197
[No Abstract] [Full Text] [Related]
38. Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant.
Doidge M; Allworth AM; Woods M; Marshall P; Terry M; O'Brien K; Goh HM; George N; Nimmo GR; Schembri MA; Lipman J; Paterson DL
Infect Control Hosp Epidemiol; 2010 Apr; 31(4):418-20. PubMed ID: 20175684
[TBL] [Abstract][Full Text] [Related]
39. Emergence of Carbapenem Resistant Non-Fermenting Gram-Negative Bacilli Isolated in an ICU of a Tertiary Care Hospital.
Agarwal S; Kakati B; Khanduri S; Gupta S
J Clin Diagn Res; 2017 Jan; 11(1):DC04-DC07. PubMed ID: 28273965
[TBL] [Abstract][Full Text] [Related]
40. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital.
Stoeva T; Higgins PG; Bojkova K; Seifert H
Clin Microbiol Infect; 2008 Jul; 14(7):723-7. PubMed ID: 18558947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
